文献速递主动脉疾病

年轻且体能状态良好患者复杂腹主动脉瘤与胸腹主动脉瘤开窗和分支腔内修复术的长期结果

Long-term results of fenestrated and branched endovascular aneurysm repair for complex abdominal and thoracoabdominal aortic aneurysms in young and fit patients.
PubMed 文献 · J Vasc Surg · 2024-07-29

研究纳入两家三级医院13年间连续183例年龄≤70岁、行开窗和分支腔内修复术(F/BEVAR)治疗复杂腹主动脉瘤和胸腹主动脉瘤的患者,平均随访65.7个月。围手术期死亡2.2%,12、60、120个月总体生存率分别为94.0%、85.1%、72.2%,主动脉相关生存率分别为97.8%、97.8%、96.2%。

要点

  • 年轻且体能状态良好患者F/BEVAR围手术期死亡率为2.2%,永久性3级脊髓损伤为2.7%。
  • 12、60、120个月总体生存率分别为94.0%、85.1%、72.2%,主动脉相关生存率分别为97.8%、97.8%、96.2%。
  • 需非计划手术是总体死亡唯一危险因素(OR 3.331,95%CI 1.397-7.940,P<.01)。

核心结论

  • 年轻且体能状态良好患者行F/BEVAR围手术期死亡率和主要并发症率低,长期总体生存率良好,使该技术在此类患者中特别有吸引力。
  • 来自年轻患者的长期数据可为重新定义治疗指征及未来器械和技术改进提供有用信息。

研究设计与样本

  • 研究为回顾性分析,纳入两家三级医院过去13年间连续183例年龄≤70岁、因复杂腹主动脉瘤和胸腹主动脉瘤行F/BEVAR的患者。
  • 所有患者根据血管外科学会临床合并症分级系统均属低至中等风险。
  • 主要终点为技术和临床成功及晚期总体和主动脉相关生存率,次要终点为主要并发症和靶血管相关结局。

主要发现

  • 共183例患者(男性155例[84.7%];平均年龄64.5±5.7岁;范围33-70岁),包括167例退行性(91.3%)和16例夹层后(8.7%)动脉瘤,其中44例(24%)近肾、33例(18%)肾周和106例(58%)胸腹主动脉瘤。
  • 技术和临床成功分别为176例(96.2%)和171例(93.4%)。
  • 围手术期死亡4例(2.2%),其中2例(1.1%)为急诊手术。
  • 术后5例(2.7%)出现永久性3级脊髓损伤,3例(1.6%)出现需永久透析的肾衰竭。
  • 平均随访65.7±39.6个月(范围1-158个月),12、60、120个月估计总体生存率分别为94.0%、85.1%、72.2%,主动脉相关生存率分别为97.8%、97.8%、96.2%,再干预和无分支不稳定生存率分别为84.4%、71.8%、71.8%和93.2%、86.3%、72.2%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular repair of complex abdominal aortic aneurysms (CAAAa) and thoracoabdominal aortic aneurysms (TAAAs) with fenestrated and branched devices (F/BEVAR) represents the first-line treatment in old or unfit patients. Currently, the widespread diffusion of these techniques has led to a progressive increase of complex endovascular procedures also in younger and fitter patients, but the related results have been only minimally reported, without long-term data. We investigated the long-term results of F/BEVAR for CAAA and TAAA repair in young and fit patients. METHODS: All consecutive patients, aged ≤70 years, who underwent F/BEVAR for CAAA and TAAA over the last 13 years at two tertiary institutions were included in the study. All subjects presented a low to intermediate risk according to the Society for Vascular Surgery clinical comorbidity grading system. The primary end points were technical and clinical success and late overall and aortic-related survival. Major complications and specific target vessel-related outcomes were investigated as secondary end points. RESULTS: A total of 183 patients (155 males [84.7%]; mean age, 64.5 ± 5.7 years; range, 33-70 years) underwent F/BEVAR during the study period, for a total of 167 degenerative (91.3%) and 16 postdissection (8.7%) aneurysms, including 44 (24%) juxtarenal, 33 (18%) pararenal, and 106 (58%) TAAAs. Technical and clinical success were achieved in 176 patients (96.2%) and 171 patients (93.4%), respectively. Four patients (2.2%) died perioperatively, of which two (1.1%) operated in emergency. Postoperatively, five patients (2.7%) presented permanent grade 3 spinal cord injury and three (1.6%) renal failure needing permanent dialysis. The mean follow-up was 65.7 ± 39.6 months (range, 1-158 months). The estimated overall and aortic-related survival at 12, 60, and 120 months was 94.0%, 85.1%, 72.2%, and 97.8%, 97.8%, 96.2%, respectively, and reintervention and branch instability-free survival at the same time points were 84.4%, 71.8%, 71.8%, and 93.2%, 86.3%, 72.2%, respectively. An aneurysm growth of >5 mm was detected in six patients (3.3%), and a sac shrinkage of >5 mm was achieved in 118 cases (64.5%). The Cox regression analysis demonstrated the need for unplanned procedure as the only risk factor for overall mortality (odds ratio, 3.331; 95% confidence interval, 1.397-7.940; P < .01]. CONCLUSIONS: F/BEVAR in young and fit patients led to low perioperative mortality and major morbidity rates and a favorable overall survival rate in the long-term, making this technique particularly appealing in such a subgroup of patients. The availability of long-term data derived from the results of young patients, may additionally provide helpful information to redefine the indications for treatment and allow future targeted device and technique improvements.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ferrer C, Gallitto E, Borghese O, et al. Long-term results of fenestrated and branched endovascular aneurysm repair for complex abdominal and thoracoabdominal aortic aneurysms in young and fit patients. J Vasc Surg. 2024. PMID: 39084495. doi:10.1016/j.jvs.2024.07.090

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。